Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Larsen

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitisD M Diamond, M Bauer, B E Daniel, et al.
International Journal of STD & AIDS|November 19, 2011
Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patientsT Anekthananon, W Manosuthi, P Chetchotisakd, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2006
In vitro-clinical correlations for amphotericin B susceptibility in AIDS-associated cryptococcal meningitisR A Larsen, M Bauer, A E Brouwer, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 2, 2008
Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated diseaseJ W Baddley, J R Perfect, R A Oster, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2011
Correlation of susceptibility of Cryptococcus neoformans to amphotericin B with clinical outcomeR A Larsen, M Bauer, P Pitisuttithum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2001
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapyP G Pappas, J R Perfect, G A Cloud, et al.
Annals of Internal Medicine|November 14, 2000
Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study GroupJ N Galgiani, A Catanzaro, G A Cloud, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 3, 2007
Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care settingL Ostrosky-Zeichner, C Sable, J Sobel, et al.
The American Journal of Medicine|October 8, 1997
Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study GroupJ Wheat, S MaWhinney, R Hafner, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Antimicrobial Agents and Chemotherapy|March 28, 1998
Amphotericin B colloidal dispersion combined with flucytosine with or without fluconazole for treatment of murine cryptococcal meningitisD M Diamond, M Bauer, B E Daniel, et al.
International Journal of STD & AIDS|November 19, 2011
Predictors of poor clinical outcome of cryptococcal meningitis in HIV-infected patientsT Anekthananon, W Manosuthi, P Chetchotisakd, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2006
In vitro-clinical correlations for amphotericin B susceptibility in AIDS-associated cryptococcal meningitisR A Larsen, M Bauer, A E Brouwer, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 2, 2008
Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated diseaseJ W Baddley, J R Perfect, R A Oster, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2011
Correlation of susceptibility of Cryptococcus neoformans to amphotericin B with clinical outcomeR A Larsen, M Bauer, P Pitisuttithum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2001
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapyP G Pappas, J R Perfect, G A Cloud, et al.
Annals of Internal Medicine|November 14, 2000
Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study GroupJ N Galgiani, A Catanzaro, G A Cloud, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 3, 2007
Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care settingL Ostrosky-Zeichner, C Sable, J Sobel, et al.
The American Journal of Medicine|October 8, 1997
Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study GroupJ Wheat, S MaWhinney, R Hafner, et al.
Pageof 9